Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 23.31 10.12 2.45 18.32 11.61
Fund with Sales Charge (%) (POP) 23.31 10.12 2.45 18.32 11.61
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49
Quarter EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 23.31 10.12 2.45 18.32 11.61
Fund with Sales Charge (%) (POP) 23.31 10.12 2.45 18.32 11.61
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49

After-Tax Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 20.87 8.76 0.96 16.82
Fund without Sales Charge (%) (NAV) After Shares Sold 15.18 7.53 1.47 15.16
Fund with Sales Charge (%) (POP) Before Shares Sold 20.87 8.76 0.96 16.82
Fund with Sales Charge (%) (POP) After Shares Sold 15.18 7.53 1.47 15.16
Quarter EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 20.87 8.76 0.96 16.82
Fund without Sales Charge (%) (NAV) After Shares Sold 15.18 7.53 1.47 15.16
Fund with Sales Charge (%) (POP) Before Shares Sold 20.87 8.76 0.96 16.82
Fund with Sales Charge (%) (POP) After Shares Sold 15.18 7.53 1.47 15.16

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
Fund with Sales Charge (%) (POP) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 29.14 13.15 23.31 33.55 12.86 437.65 1,121.21
Fund with Sales Charge (%) (POP) 29.14 13.15 23.31 33.55 12.86 437.65 1,121.21
NASDAQ Biotechnology Index (%) 26.68 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) 20.54 -3.08 7.51 35.77 66.45 270.31 418.39
Quarter EndAs of 06/30/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 29.14 13.15 23.31 33.55 12.86 437.65 1,121.21
Fund with Sales Charge (%) (POP) 29.14 13.15 23.31 33.55 12.86 437.65 1,121.21
NASDAQ Biotechnology Index (%) 26.68 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) 20.54 -3.08 7.51 35.77 66.45 270.31 418.39

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 06/30/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 23.77 25.69 23.12
Standard Deviation (NASDAQ Biotechnology Index) 22.16 24.09 21.31
Beta 1.03 1.04 1.05
Sharpe Ratio 0.36 0.05 0.77
Information Ratio 0.05 0.05 -0.02
Tracking Error 6.28 5.95 6.15

ADDITIONAL RISK STATISTICSAs of 06/30/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 0.95 0.92 1.02
Beta Bear 0.92 1.00 1.02
Bull Bear Capture Ratio 1.04 1.06 1.00
% of Positive Months 55.56 55.00 61.67
Gains/Losses 1.46 1.18 1.86
Maximum Drawdown
23.49 37.55 37.55

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 06/30/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.36
Standard Deviation 23.77

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index